Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +16.00%·Rev n/aQ2 22EPS -16.98%·Rev n/aQ1 22EPS -12.73%·Rev n/aQ4 21EPS -19.61%·Rev n/a⚠ consensus missing

Wave Life Sciences, Inc. WVE

Kate Rausch — VP of Investor Relations and Corporate Communications

Paul Bolno — President and Chief Executive Officer

Anne-Marie Li-Kwai-Cheung — Chief Development Officer

Kyle Moran — Chief Financial Officer

+5.8%1d on move date+0.3% vs SPY3d−13.7%5d−15.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WVE calls or request research access.

More WVE calls Browse calls Request research access